Akihiro Ono

730 citations
44 papers · 568 indexed · h-index 14
Topics
Lung Cancer Treatments and Mutations (7 papers)Asthma and respiratory diseases (6 papers)Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers)

In The Last Decade

Akihiro Ono

37 papers receiving 559 citations

Peers

Akihiro Ono
Comparison fields: 5 of 87
  • Molecular Biology 148
  • Immunology 143
  • Pulmonary and Respiratory Medicine 142
  • Physiology 141
  • Oncology 93
Replace Hiroaki Tsurumaki with:
Hiroaki Tsurumaki Japan
Tadayoshi Kawata Japan
Naohiro Yamashita Japan
Sachiko Nishimoto Japan
Preeti Kanikarla Marie United States
Satoshi Aiko Japan
Giovanna Baccante Italy
Xinming Xie China
Naijun Miao China
NF Voelkel United States
Akihiro Ono relative to Hiroaki Tsurumaki Japan Hiroaki Tsurumaki's profile →
Citations per field
00.5×2.6×
Hiroaki Tsurumaki · 1×
Citations per year

Countries citing papers authored by Akihiro Ono

Since Specialization
Citations

This map shows the geographic impact of Akihiro Ono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akihiro Ono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akihiro Ono more than expected).

Fields of papers citing papers by Akihiro Ono

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akihiro Ono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akihiro Ono. The network helps show where Akihiro Ono may publish in the future.

Co-authorship network of co-authors of Akihiro Ono

This figure shows the co-authorship network connecting the top 25 collaborators of Akihiro Ono. A scholar is included among the top collaborators of Akihiro Ono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akihiro Ono. Akihiro Ono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 1
5 7
6 3
7 1
8 25
9 4
10 3
11 15
12 7
13 7
14 42
15 26
16 72
17 31
18 21
19 1
20 2

About Akihiro Ono

Akihiro Ono is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Immunology, having authored 44 papers that have together received 568 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (7 papers), Asthma and respiratory diseases (6 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers). The work is most often cited by research in Biochemistry (55 citations), Immunology (143 citations) and Physiology (141 citations). Akihiro Ono has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Takeshi Hisada, Kunio Dobashi, Tamotsu Ishizuka, Mitsuyoshi Utsugi, Masatomo Mori, Yasuo Shimizu, Yasuhiko Koga, Haruka Aoki, Tadayoshi Kawata and Yosuke Kamide. Their work appears in journals such as The Journal of Immunology, PLoS ONE and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026